Adaptive Biotechnologies Corp
Change company Symbol lookup
Select an option...
ADPT Adaptive Biotechnologies Corp
TDOC Teladoc Health Inc
SPNE SeaSpine Holdings Corp
GBT Global Blood Therapeutics Inc
NYMT New York Mortgage Trust Inc
HY Hyster-Yale Materials Handling Inc
NTES NetEase Inc
EV Eaton Vance Corp
IPG Interpublic Group of Companies Inc
DDD 3D Systems Corp

Company profile

Adaptive Biotechnologies Corp is a biotechnology company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform generates clinical immunomics data to decode the adaptive immune system. Its products and pipeline includes immunoSEQ, clonoSEQ and cellular therapy. It offers its immunoSEQ technology as a service and a kit. immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA). clonoSEQ is its diagnostic test product for the detection and next-generation sequencing (NGS)-based monitoring of minimal residual disease (MRD) in bone marrow samples in patients with myeloma (MM) and acute lymphoblastic leukemia (ALL). clonoSEQ is designed to sequence all rearranged receptor sequences in a tumor in parallel to enable MRD monitoring. It also focuses on developing immune-mediated therapies in oncology and other disease areas.

Day's Change
0.21 (0.70%)
B/A Size
Day's High
Day's Low

Today's volume of 107,352 shares is on pace to be much lighter than ADPT's 10-day average volume of 855,038 shares.


Avis Budget's new chairman buys $15 million worth of stock

8:42 am ET February 10, 2020 (MarketWatch)

Avis Budget Group Inc. (CAR) named a new independent chairman of the board, and got a $15 million stock investment to boot. The car rental company said Bernardo Hees will be the new chairman, succeeded Leonard Coleman will continue as a board member. Previously, Hees has been chief executive of Kraft Heinz Co. (KHC), Restaurant Brands International Inc.'s (QSR.T) Burger King Worldwide Holdings Inc. and America Latina Logistica over the past 15 years. Hees is investing $15 million in Avis's stock at Friday's closing price of $34.87, "to align his interests with those of all shareholders." The investment represents about 0.6% of the shares outstanding. Avis stock, which was still inactive in premarket trading, has rallied 13.4% over the past three months, while rival Hertz Global Holdings Inc. (HTZ) shares have edged up 1.0% and the S&P 500 has gained 7.6%.

-Tomi Kilgore; 415-439-6400;

(END) Dow Jones Newswires

February 10, 2020 08:42 ET (13:42 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.